European VitreoRetinal Society a certain philosophy

http://www.dailymotion.com/video/xn6a0u http://www.dailymotion.com/video/xn6a1e http://www.dailymotion.com/video/xn6a2o Vito Primavera, Isabella Turco, N. Delle Noci (Foggia, Italy) Advantages: To compare the anatomical outcome following small gauge vitrectomy for rhegmatogenous retinal detachment (RRD) between triamcinolone acetonide assistance and chandelier illumination system. Methods: Retinal detachment repair was performed by the same...

http://www.evrs.eu/medias/2008/congress/Safe-Methods-in-Vitreo-Retinal-Procedures-During-Complicated-Retinal-Detachment-Cases.flv I.N.Serezhin, V.K. Surkova, Z.A.Dautova, M.X.Zakirzjanov Advantages: To evaluate the effectiveness of safe surgical techniques and instruments in treating proliferative vitreoretinopathy (PVR) retinal detachment. Methods: Results of vitreoretinal operations in proliferative vitreoretinopathy (PVR) retinal...

http://www.evrs.eu/medias/2008/congress/Early-Injection-and-Different-Inoculation-Site-of-Triamcinolone-During-Pars-Plana-Vitrectomy.flv Mario Facino, Benedetto Mochi, Elena Guglielminetti, Fabio Giacomelli Advantages: We have developed a safe, simple method using a cheap and easy to assemble device that allows us to carry out early, reliable Triamcinolone injection during three-port pars plana vitrectomy. Methods: In an interventional...

Zeliha Yazar, Nil Ýrem Uçgun, Dilay Ozek Purpose: To find out the efficiency of posterior subtenon triamcinolone acetonid (PSTA) injections and possible complications. Materials and Methods: 40 eyes of 22 patients (22 male, 14 female, with an average age of 36.8 (15-55) years) were studied in our clinic. Visual acuity changes, vitritis, retinal vasculitis or/and cystoid macular oedema (CME), the increase in intraocular pressure (IOP) and...

http://www.evrs.eu/medias/2008/congress/The-Snowstorm-Technique:-Triamcinolone-Suspension-in-the- Infusion-Bottle.flv Enrico Bertelli Advantages: Triamcinolone Acetonide (TA)-assisted vitrectomy has been first described in 2000, and has become popular among vitreoretinal surgeons. Vitreous staining properties of TA suspension in the conventional use improve visualization of vitreous fibers and vitreoretinal interface. However they offer...

http://www.evrs.eu/medias/2006/congress/Triamcinolone-Acetonide-in-Silicone-filled-Eyes-as-Adjunctive-Treatment-for-Proliferative-Vitreoretinopathy;-a-Randomized-Clinical-Trial.swf Hamid Ahmadieh, MD (Tehran, Iran), Homa Tabatabaei, MD (Tehran, Iran), Mostafa Feghi, MD (Ahvaz, Iran), Ardeshir Papi, MD (Tehran, Iran), Alireza Ramezani, MD (Tehran, Iran), Touka Banaee, MD (Mashhad, Iran) PURPOSE: To evaluate the effect of triamcinolone...

Ashraf Shoukry, (Doha Qatar, Saudi Arabia), Walid A. Alturki, MD (Jeddah, Saudi Arabia) PURPOSE: Can 4mg intravitreal triamcinalone acetonide effectively treat diabetic macular edema that is refractory to conventional laser treatment? METHODS: 50 eyes were enrolled in the study. Preinjection best corrected visual acuity; intraocular pressure and optical coherence tomography were done for each patient. Intraocular injection of 4 mg of...

Alireza Ramezani, (Tehran, Iran), Homa Tabatabaei, MD (Tehran, Iran), Hamid Ahmadieh, MD (Tehran, Iran) PURPOSE: The therapeutic effect of intravitreal triamcinolone (IVT) on diabetic macular edema (DME), which is a chronic disease, has been shown to be temporary. This study was conducted to compare IVT treatment effect with the natural course of refractory DME in a particular group of the eyes. We chose one group for both interventions to...

Giampaolo Gini, MD (Prato, Italy), Vincent S. Reppucci, MD (New York, NY) SYNOPSIS New techniques and devices are helping us deal successfully with complex trauma cases. Drainage implants have proved reliable where no other option for controlling IOP is available. Posterior hyaloid identification with Triamcinolone and its consequent removal accounts for fewer mid- and long-term retinal complications. Finally, the laser-assisted corneal...

Osman Cekic, MD, PhD (Isparta, Turkey), Yavuz Bardak, MD (Isparta, Turkey), Uzeyir Y ´ yld´ yzoglu, MD (Isparta, Turkey), Sahin Ufuk T ´ yg, MD (Isparta, Turkey) PURPOSE: To quantify the disappearance of plaque-like hard exudates after 4 mg intravitreal triamcinolone acetonide injection in eyes with diabetic macular edema. METHODS: This retrospective interventional case series included 22 eyes of 14 patients with chronic diabetic macular...

Osman Cekic, MD, PhD (Isparta, Turkey), Yavuz Bardak (Isparta, Turkey), Aykut Demirkol, MD (Isparta, Turkey), Ahmet Yepildao, MD (Isparta, Turkey), Mustafa Yalç ´ yn, MD (Isparta, Turkey), Orhan Oyar, MD (Isparta, Turkey) PURPOSE: To investigate ocular hemodynamic changes after intravitreal triamcinolone acetonide injection in patients with diabetic macular edema. METHODS: Prospective interventional case-control study. Thirteen eyes of 13...

Yavuz Bardak, MD (Isparta, Turkey), Osman Cekic, MD, PhD (Isparta, Turkey), Ufuk Sahin Tig, MD (Isparta, Turkey), Aykut Arslan Yildiz, MD (Isparta, Turkey) PURPOSE: To investigate effects of intravitreal triamcinolone injection on macular functions in patients with diabetic macular edema. METHODS: Intravitreal triamcinolone (4mg) injection was applied to 18 eyes of 18 subjects (Type II Diabetus Mellitus, mean age 57, M/F:9/9) with diabetic...

Leyla S. Atmaca, MD (Ankara, Turkey), Elif Akmese, MD (Ankara, Turkey), Selcen Celik, MD (Ankara, Turkey) PURPOSE: To evaluate the efficacy of the intravitreal triamcinolone acetonide injection in the treatment of diabetic maculopathy. METHODS: This prospective, non-randomized, uncontrolled study included patients with diabetic maculopathy who were treated with 4 mg (0.1 ml) of triamcinolone acetonide intravitreally. Full ophthalmic...

http://www.evrs.eu/medias/2006/congress/Posterior-Juxtascleral-Injection-of-Triamcinolone-Acetonide-for-Cases-of-Diabetic-Macular-Edema-Unresponsive-or-Unamenable-to-Laser-Treatment.swf Franco M. Recchia, MD (Nashville, TN), Jaclyn Lekse Kovach, MD (Nashville, TN), Guri Bronner, MD (Nashville, TN), Srilakshmi Maguluri, MD (Nashville, TN) PURPOSE: The risks of endophthalmitis, retinal detachment, and glaucoma associated with intravitreal...

http://www.evrs.eu/medias/2006/videos/Triamcinolone-Asssisted-Vitrectomy-in-Treating-Vitreoretinal-Interface-Abnormalities.flv Maria Stefaniotou, (Ioannina, Greece), Ekaterini Christodoulou, (Ioannina, Greece), Eleni Bagli, MD, PhD (Ioannina, Greece), Spiridon Gorezis, MD (Ioannina, Greece), Christos D. Kalogeropoulos, MD, PhD (Ioannina, Greece), Miltiadis Aspiotis, MD, PhD (Ioannina, Greece) SYNOPSIS Residual vitreous cortex is a scaffold...

http://www.evrs.eu/medias/2006/videos/Preservative-Free-Triamcinolone-Acetonide-(PFTA)-as-an-Adjuvant-in-Vitreoretinal-Surgery.flv Arturo Santos, MD, PhD (Guadalajara, Mexico), Enrique A. Roig-Melo, MD PhD (Guadalajara, Mexico), Miguel Castellanos, MD (Guadalajara, Mexico), Ramon Flores- Fuentes, MD (Guadalajara, Mexico), Monica A. Ayala-Fernandez, MD (Guadalajara, Mexico), Iban Flores, MD (Guadalajara, Mexico) SYNOPSIS Many strategies have...

Morteza Mehdizadeh, MD (Shiraz, Iran) PURPOSE: To asses the effect of intravitreal Triamcinolone Acetonide in silicone filled eye to prevent presilicone fibrosis (PSF) and proliferative vitreoretinopathy. METHODS: 4 eyes of 4 patients with early PSF and PVR changes in inferior retina 10-14 days after pars plana vitrectomy and silicone oil injection were taken. 0.1 ml, 4mg Triamcinolone Acetonide was injected through pars plana. The...

Daniel B. Roth, MD (New Brunswick, NJ), Nancy E. Martin, PharmD, FCP (New Brunswick, NJ), Jonathan L. Prenner, MD (New Brunswick, NJ) PURPOSE: The empiric dose of 4mg in 0.1mL triamcinolone acetonide (TA) administered via intravitreal injection has demonstrated promising results for macular diseases. Variability of the actual dose delivered has been a concern with the use of Kenalog®-40 suspension. Herein, we evaluate the reproducibility...

Tamer Macky, MD (Cairo, Egypt), Dina Helmy, MD (Cairo, Egypt), Nihal El Shazly, MD (Cairo, Egypt) PURPOSE: To assess rabbit retinal toxicity to triamcinolone acetonide vehicle, benzyl alcohol, when injected intravitreally. METHODS: This prospective comparative experimental study included 24 pigmented rabbits assigned into 2 groups; group 1 (experiment, n=12) received intravitreal 0.1ml of benzyl alcohol (BA), and group 2 (control, n=12)...

Adiel Barak, MD (Tel Aviv, Israel), Anat Loewenstein, MD (Tel Aviv, Israel) PURPOSE: Infectious endophthalmitis following intravitreal triamcinolone injections (IVTA) can result in severe loss of vision when treated in a fashion similar to the endophthalmitis vitrectomy Study recommendations. We want to report outcomes of six eyes who developed acute postoperative endophthalmitis following IVTA and were treated with early vitrectomy and...

Ferenc Kuhn, MD, PhD (Birmingham, AL), Zsuzsanna Szijarto, MD (Pecs, Hungary), Gyongyi Kiss, MD (Pecs, Hungary) PURPOSE: Intravitreal triamcinolone acetate injection has become very popular for treating a variety of conditions ranging from macular edema to age-related macular degeneration. Its complication rate, however, needs to be closely evaluated. METHODS: A prospective study was undertaken to evaluate the postoperative complications of...

Eric R. Holz, MD (Houston, TX), Thomas A. Albini, MD (Houston, TX), Muhammad M. Abd- El-Barr, (Houston, TX), Petros E. Carvounis, BM, BCh (Houston, TX), Mohan N. Iyer, MD (St. Petersburg, FL), Rohit R. Lakhanpal, MD (Houston, TX), Mark E. Pennesi,(Houston, TX), Patricia Chevez-Barrios, MD (Houston, TX), Samuel M. Wu, PhD (Houston, TX) PURPOSE: To investigate whether IVTK produces histological or electroretinographic changes in the rabbit...

http://www.evrs.eu/medias/2006/videos/Vitreous-Cutter-assisted-Triamcinolone-and-or-PFCL-Infusion.flv Spyridon Mourtzoukos, MD (Athens, Greece), Giorgos Morphis, MD (Athens, Greece), Manolis Gogos, MD (Athens, Greece), Elias Feretis, MD (Athens, Greece) SYNOPSIS During vitrectomy the vitreous cutter may removed and a blunt needle is inserted to inject substances in the vitreous cavity such as triamcinolone, or PCFL. In our technique, the...

http://www.evrs.eu/medias/2006/videos/Stardust-Triamcinolone-Acetonide-in-Macular-Surgery.flv Joseph Moisseiev, MD (Tel Aviv, Israel) SYNOPSIS The film demonstrates how injection of Triamcinolone acetonide during vitrectomy improves the visibility of residual cortical vitreous in three cases: a case of vitreomacular traction syndrome, diabetic macular edema in an eye with PDR, and very thin ERM following PVD with multiple retinal breaks....

http://www.evrs.eu/medias/2006/videos/Pars Plana Vitrectomy Alone for the Management of Rhegmatogenous-Retinal-Detachment:-The-Importance-of-Using-a- Chandelier-Illumination.flv Vicente Martinez-Castillo, MD (Barcelona, Spain), Anna Boixadera, MD (Barcelona, Spain), Miguel A. Zapata, MD (Barcelona, Spain), José García-Arumí, MD (Barcelona, Spain) SYNOPSIS This video describes the main advantages of using a 25-gauge sutureless xenon...

Lihteh Wu, MD (San Jose, Costa Rica), Teodoro Evans, MD (San Jose, Costa Rica), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela), Maria H. Berrocal, MD (Santurce, PR), Francisco J. Rodriguez, MD (Bogota, Colombia), Maria Hsu, MD (San Jose, Costa Rica), Juan G. Sanchez, MD (Caracas, Venezuela) PURPOSE: To report the visual outcome and ocular complications of an intravitreal injection of triamcinolone (IVT) in the treatment of macular edema...

Vicente Martinez-Castillo, MD (Barcelona, Spain), Anna Boixadera, MD (Barcelona, Spain), Miguel A. Zapata, MD (Barcelona, Spain), José García-Arumí, MD (Barcelona, Spain) SYNOPSIS This video describes the main advantages of using a 25-gauge sutureless xenon chandelier light during Pars Plana Vitrectomy for the surgical repair of rhegma-togenous retinal detachment: Peripheral scleral depression by the surgeon, improved fundus view during...

Rishi P. Singh, MD (Shaker Heights, OH), Oswaldo FM Brasil, MD (Cleveland, OH), Anat Galor, MD (Cleveland, Ohio), Scott D Smith, MD, MPH (Cleveland, OH), Careen Y. Lowder, MD (Cleveland, OH), Jonathan E. Sears, MD (Cleveland, OH), Peter K. Kaiser, MD (Cleveland, OH) PURPOSE: To evaluate the predictive factors for visual outcome after intravitreal triamcinolone acetonide injection in the treatment of diabetic macular...

http://www.evrs.eu/medias/2006/congress/The-Effect-of-an-Epiretinal-Membrane-on-Intravitreal-Triamcinolone-Treatment-for-Diabetic-Macular-Edema.swf Parin S. Gohel, MD (Denver, CO), Gian Paolo Giuliari, MD (Caracas, Venezuela), Antonio P. Ciardella, MD (Denver, CO) PURPOSE: To evaluate the efficacy of intravitreal triamcinolone injection (IVTA) for the treatment of diabetic macular edema (DME) in eyes with an epiretinal membrane (ERM)...

Alireza Ramezani, MD (Tehran, Iran), S. Morteza Entezari (Tehran, Iran), Siamak Moradian, MD (Tehran, Iran), Homa Tabatabaei, MD (Tehran, Iran), Shohreh Kadkhodaei, MD (Tehran, Iran) PURPOSE: Central retinal vein occlusion (CRVO) is the most common vascular event in the eye after diabetic retinopathy. This study was conducted to evaluate the therapeutic effect and safety of intravitreal triamcinolone acetonide (IVT) in acute...

http://www.evrs.eu/medias/2006/videos/The-Use-of-New-Surgical-Strategies-in-Dealing-with-Ocular-Trauma.flv Giampaolo Gini, MD (Prato, Italy), Vincent S. Reppucci, MD (New York, NY) SYNOPSIS New techniques and devices are helping us deal successfully with complex trauma cases. Drainage implants have proved reliable where no other option for controlling IOP is available. Posterior hyaloid identification with Triamcinolone and its consequent...

Ron A. Adelman, MD, MPH (New Haven, CT), Adarsh Arya, MD (New Haven, CT), John Emerson, PhD (New Haven, CT) PURPOSE: To study predictive factors that determine visual improvement following intravitreal triamcinolone acetonide for macular edema in diabetes and retinal vein occlusions. METHODS: A meta-analysis was performed on the articles reporting functional outcome following intravitreal triamcinolone in macular edema associated with...

Dong Heun Nam, MD (Incheon, Korea), Jee Woong Jeung, MD (Incheon, Korea), Kyung Hwan Shyn, MD, PhD (Incheon, Korea) PURPOSE: This study was performed to ascertain the complication, intraocular pressure(IOP) elevation and cataract formation, arisen after 4.0 mg triamcinolone (TA) is injected into vitreous cavity in curing retinal diseases, and to analyze the influential factors. METHODS: The 289 patients and 325 eyes traced for over 6...

Baruch D. Kuppermann, MD, PhD (Irvine, CA), Raja Narayanan, MD (Irvine, CA), Saurabh Luthra, MD (Irvine, CA), L. E. Marques, MD (Irvine, CA), Aneesh Neekhra, MD (Irvine, CA), Maria C. Kenney, MD (Irvine, CA) PURPOSE: To study the toxicity of the steroids triamcinolone acetonide (Kenalog®), preservative free triamcinolone (PFTA), dexamethasone, betamethasone, and methyl prednisolone acetate (Depomedrol®) on retinal pigment epithelial...

Jose Garcia-Arumi, MD (Barcelona, Spain), Miguel Angel Zapata, MD (Barcelona, Spain), Anna Boixadera, MD (Barcelona, Spain), Alejandro Fonollosa, MD (Barcelona, Spain), Jorge Prieto, MD (Barcelona, Spain), Vicente Martinez-Castillo, MD (Barcelona, Spain) PURPOSE: RON has been proposed to relieve the pressure exerted by scleral ring in CRVO. Vitrectomy, intravitreal triamcinolone and ILM peeling seem to be effective for treating macular...

Yusuf Akar, Cemil Apaydin, Meryem Altin, Asli Oner Purpose: To assess the effects of intravitreal triamcinolone acetonide injection on optic nerve head topography. Methods: The study population consisted of one eye of 23 patients with type 2 diabetes mellitus with clinically significant macular edema. None of the patients had proliferative diabetic retinopathy or a history of retinal laser photocoagulation. All eyes had received 4 mg of...

Yun-Sik Yang, Cang-uk Choi, Yong-Woo Kim Purpose: To evaluate the difference of intravitreal triamcinolone acetonide in the management of macular edema secondary to perfusion type and ischemic type branch retinal vein occlusion (BRVO). Methods: 44 patients consecutive patients were selected with a BRVO with macular edema. 23 were perfusion type and twenty one were ischemic type BRVO. These patients received a single intravitreal injection...

N. Acar, M. Çakır, Y. B. Ünver, Z. Kapran, T. Altan, Z. Bayraktar, E. Y. Pınarcı, I. Perente, M. Dogan Purpose: To evaluate the efficacy of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of macular edema (ME) due to branch retinal vein occlusion (BRVO) by OCT. Methods: In this prospective study, a total 42 eyes of 42 patients with BRVO in which visual acuity is ≤ 0.5 Snellen lines with ME were included in...

http://www.evrs.eu/medias/2005/congress/Intravitreal-Triamcinolone-(IVT)-for-Diabetic-Massive-Macular-Hard-Exudates.swf S. Ben Yahia , B. Jelliti, K. Hmidi, F. Amouri, S. Attia, R. Messaoud, A. Ladjimi, M. Khairallah Purpose: To evaluate the efficacy of intravitreal triamcinolone acetonide (TA) as treatment for massive macular hard exudates in diabetic patients. Methods: Prospective, noncomparative, interventional case series, of twelve...

Murat Karacorlu, Hakan Ozdemir, Serra Arf Karacorlu Purpose: To evaluate the effect of intravitreal triamcinolone acetonide on serous macular detachment in eyes with diabetic cystoid macular edema (CME). Methods: Twenty eyes of 20 patients with diabetic macular edema made up the study population. The eligibility criteria for this study included clinically detectable CME in which the presence of serous macular detachment was documented by...

http://www.evrs.eu/medias/2005/congress/Combined-treatment:-Photodynamic-therapy-with-visudyne-and-intravitreous-injection-of-triamcinolone-(IVT).swf Guy L’Helgoual’ch Purpose: To estimate the interest of intravitreous injection of Triaminolone 24 hours after Photodynamic Therapy with Visudyne used as treatment of néovascular complications of age related macular degeneration. Methods: During a period longer than 2 years, each patient...

http://www.evrs.eu/medias/2005/congress/Intravitreal-Triamcinolone-Acetonide-Injection-for-the-Management-of-Diabetic-Macular-Edema.swf Mehmet Cakir, MD, C. Aslı Utine, MD, Nur Acar, MD, Y. Banu Ünver, MD, Muhammed Beyazal, MD, Irfan Perente, MD, Tugrul Altan, MD, Zerrin Bayraktar, MD, E. Yaman Pınarcı, MD, Ziya Kapran – Beyoglu Eye Research and Education Hospital, Istanbul Purpose: To evaluate the efficacy of intravitreal...

http://www.evrs.eu/medias/2005/congress/Confounding-Factors-on-the-Effect-of-Intravitreal-Triamcinolone-for-Refractory-Diabetic-Macular-Edema.swf Ali R. Ramezani, MD, Hamid Ahmadieh, MD Purpose: To evaluate the influences of different confounding factors on the effect of intravitreal triamcinolone acetonide (IVTA) for refractory diabetic macular edema (DME) according to clinical, angiographic and optical coherence tomographic...

http://www.evrs.eu/medias/2005/congress/Intravitreal-Triamcinolone-Acetonide-(IVTA)-for-Diabetic-Macular-Edema-(DME):-Primary-vs-Secondary.swf B. V. Kumar, L. Dhir, C. Murphy, S. Prasad Purpose: To compare benefit of IVTA in patients with DME as a Primary treatment option or as Secondary option after laser treatment. Methods: Non-randomised retrospective case review was done of 8 patients with DME who had undergone treatment with...

Giampaolo Gini Purpose: To present the indications and the limits of triamcinolone in the treatment of macular conditions both as single treatment by itself, as a preparatory step for further procedures or an intraoperatory instrument. Methods: In dealing with macular edema understanding the causes determining the condition is essential in choosing a successful therapeutic strategy. Thus, triamcinolone finds different indications according...

http://www.evrs.eu/medias/2005/congress/Photodynamic-therapy-in-the-treatment-of-retinal-angiomatous- proliferation-(RAP).swf Márcio Nehemy, MD, PhD, Erika Magalhães, MD, PhD, Patrícia Nehemy, MD Purpose: To evaluate photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP). Methods: Thirty eight eyes of thrity one consecutive patients with RAP were treated with PDT. Fifteen of these eyes received also an intravitreous...

http://www.evrs.eu/medias/2005/congress/Does-Using-Intravitreal-Triamcinolone-Acetonide-During-ILM-Peeling-Affect-the-Outcome-of-Macular-Hole-Surgery.swf Murat Karacorlu, Hakan Ozdemir, Serra Arf Karacorlu Purpose: To evaluate functional and anatomical outcome of triamcinolone acetonide assisted internal limiting membrane (ILM) peeling in patients with macular hole. Methods: Fifteen eye of 15 consecutive patients were identified with stage...

http://www.evrs.eu/medias/2005/congress/Kenalog-Assisted-Removal-of-ILM-in-Macular-Hole-Surgery.swf Theodoros Potamitis Purpose: To assess the value of kenalog coating in the removal of ILM for macular hole surgery. Methods: The results of 44 cases of macular holes, stages III and IV, treated surgically are reviewed. The results of cases performed without kenalog (18) are compared to those in which kenalog was used to aid the removal of the...

http://www.evrs.eu/medias/2005/congress/Vitreoretinal-Surgery-for-Epiretinal-Membranes-(ERM).flv N. Acar, Y. B. Ünver, M. Çakır, Z. Kapran, T. Altan, Z. Bayraktar, Z. Kayaarası Idiopathic epiretinal membranes leads to vision loss due to macula edema, dense membrane over the fovea or sensory foveal elevation. In secondary ERMs other retinal pathologies contribute to the vision loss. Increase in visual acuity is achieved with pars plana...

S. Bopp Purpose: To present different staining patterns in various macular diseases and discuss their significance with respect to the underlying pathology. Introduction: Ophthalmoscopically, many cases designed for macular surgery show subtle clinical findings that may be difficult to interpret. OCT has shown to be a valuable tool in planning the surgical strategy, and visualization aids allow meticulous surgery in...